Product Images Valproate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Valproate Sodium NDC 70860-784 by Athenex Pharmaceutical Division, Llc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Valproate Sodium Structure - val06 0000 01

Valproate Sodium Structure - val06 0000 01

Figure 1 - val06 0000 02

Figure 1 - val06 0000 02

This is a graph showing the percentage reduction in CPS rate for patients taking Divalproex Sodium compared to a placebo. It indicates that Divalproex Sodium results in a 50% reduction in CPS rate for some patients. The graph also shows the divisions between improvement, no change, and worsening.*

Figure 2 - val06 0000 03

Figure 2 - val06 0000 03

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label - val06 0000 04

PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – Vial Label - val06 0000 04

This is a description of a medication - Sodium Injection, USP with Valproic Acid (activity 253) - that was made in India and manufactured for Athenex in Schaumburg, IL. The National Drug Code (NDC) is 70860-784-41 and the medication should only be used for infusion. The packaging includes information regarding the medication's strength, volume, and ingredients.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.